Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Jeremy Hurren"'
Autor:
Geoffrey J. Pilkington, Verena Amberger-Murphy, Louise A. Knight, Anne Suovouri, Katharine A. Parker, Sharon Glaysher, Deidre McCormick, Jeremy Hurren, Ian A. Cree
Publikováno v:
Anti-Cancer Drugs. 23:65-69
The tricyclic antidepressants have previously been shown to exert activity against glioma cells in vitro. Initial studies in cell lines suggested that this might extend to melanoma cells. We have therefore conducted a study in primary cell cultures f
Autor:
Francis G Gabriel, Martine J. Jager, Penny Johnson, Marta E Polak, D McCormick, Ian A. Cree, Bernard Higgins, Jeremy Hurren, Nicola J Borthwick
Publikováno v:
British Journal of Cancer
Cutaneous melanoma is highly immunogenic, yet primary melanomas and metastases develop successfully in otherwise immunocompetent patients. To investigate the local immunosuppressive microenvironment, we examined the presence of suppressor T lymphocyt
Autor:
Jeremy Hurren
Publikováno v:
Journal of plastic, reconstructiveaesthetic surgery : JPRAS. 68(1)
Publikováno v:
Aesthetic Surgery of the Breast ISBN: 9783662434062
The Wise pattern breast reduction is a standard technique used to allow resection of tumours through a breast reduction technique. However, many breast cancers occur in the breast outside the area that is normally resected with a Wise pattern breast
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b3da1a14d9c8bd5fada107c14b412ba9
https://doi.org/10.1007/978-3-662-43407-9_55
https://doi.org/10.1007/978-3-662-43407-9_55
Autor:
Scott C. Edmunds, F Di Nicolantonio, Ian A. Cree, David P. Kelsell, John L. Hungerford, Jeremy Hurren
Publikováno v:
British Journal of Cancer
The recent discovery of activating mutations in the BRAF gene in many cutaneous melanomas led us to screen the genomic sequence of BRAF exons 11 and 15 in a series of 48 intraocular (uveal) melanomas, together with control samples from three cutaneou
Publikováno v:
Journal of plastic, reconstructiveaesthetic surgery : JPRAS. 66(2)
The upper outer quadrant of the breast is the most common site for the incidence of breast cancer, and the upper inner quadrant the most cosmetically sensitive area. If an oncoplastic approach is considered however, these quadrants do not fall within
Autor:
Sharon Glaysher, Jeremy Hurren, Ajit Narayanan, Ian A. Cree, Francis G Gabriel, Louise A. Knight, Penny Johnson, Katharine A. Parker, Matthew Poole, Marta E Polak
Publikováno v:
Journal of clinical pathology. 63(11)
Background Chemotherapy benefits relatively few patients with cutaneous melanoma. The assessment of tumour chemosensitivity by the ATP-based tumour chemosensitivity assay (ATP-TCA) has shown strong correlation with outcome in cutaneous melanoma, but
Autor:
Sharon Glaysher, Sanjay Sharma, Louise A. Knight, Alan Lamont, Jeremy Hurren, Stuart Mercer, Pauline A. Whitehouse, Ian A. Cree, Federica Di Nicolantonio, John L. Hungerford
Publikováno v:
Anti-cancer drugs. 17(6)
Imatinib mesylate is a specific inhibitor of the Bcr-Abl protein tyrosine kinase that competes with ATP for its specific binding site in the kinase domain. It has activity against platelet-derived growth factor receptor alpha and beta (PDGFR-alpha an
Autor:
Martine J. Jager, Deirdre Mccormick, Penny Johnson, Silvana Di Palma, Bernard Higgins, Jeremy Hurren, Nicola J Borthwick, Ian A. Cree, Marta E Polak
Publikováno v:
The Journal of pathology. 207(1)
Immune avoidance mechanisms play a key role in the successful dissemination of melanoma. One mechanism whereby this could be achieved is by interfering with dendritic cell (DC) presentation of tumour-associated antigens to naive T cells. In particula
Autor:
Silvana Di Palma, Constantinos Yiangou, Ian A. Cree, Sanjay Sharma, Federica Di Nicolantonio, Jeremy Hurren, Sharon Glaysher, Shaw Somers, Augusta Fernando, Alan Lamont, Penny Johnson, Bernard Higgins, Francis G Gabriel, Pauline A. Whitehouse, Stuart Mercer, Tim J. Gulliford, Louise A. Knight, Simon Toh
Publikováno v:
BMC Cancer, Vol 5, Iss 1, p 78 (2005)
BMC Cancer
BMC Cancer
Background Tumor resistance to chemotherapy may be present at the beginning of treatment, develop during treatment, or become apparent on re-treatment of the patient. The mechanisms involved are usually inferred from experiments with cell lines, as s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d782e3cf0a4a786c8d0af2408883dd0d
http://hdl.handle.net/2318/127007
http://hdl.handle.net/2318/127007